Tag: interventional oncology
First patient treated with Epione robot in USA
Govindarajan Narayanan, chief of interventional oncology at Miami Cancer Institute and a vascular interventional radiologist with Miami Cardiac & Vascular Institute (both Miami, USA),...
IO of the past, present and future: presentation predicts what is...
Setting the audiences sights on the horizon at the 2023 Global Embolization Oncology Symposium (GEST, 18–21 May, New York City, USA) yesterday, Daniel Sze...
Varian introduces Isolis cryoprobe to simplify planning and guidance during cryoablation...
Varian, a Siemens Healthineers company, is introducing the Isolis cryoprobe, a single-use, disposable device designed for use with CryoCare systems that seeks to...
American Urological Association recommends tumour ablation for kidney sparing
The American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), released the 2023 clinical practice guidelines for the diagnosis and...
Cryoablation for renal cell carcinoma: Where do we stand? Where are...
Christos Georgiades (Johns Hopkins University, Baltimore, USA), delves into the various national society guidelines for treating renal cell carcinoma (RCC), what the ‘gold standard’...
Delcath Systems announces US FDA acceptance of Hepzato Kit new drug...
Delcath Systems has announced in a company press release that the US Food and Drug Administration (FDA) has accepted its (Delcath's) new drug application...
PAIRS 2023: What the BCLC guidelines have omitted
Sarah White (Medical College of Wisconsin, Milwaukee, USA) opened the liver interventional oncology (IO) session at the Pan Arab Interventional Radiology Society (PAIRS) annual...
Histotripsy: New technology making waves in IO
Mina S Makary, assistant professor at the Division of Vascular and Interventional Radiology/Department of Radiology at the Ohio State University Wexner Medical Center (Columbus,...
Patient-centric care: Recognising the value of non-clinical intervention
During the Society of Interventional Oncology (SIO) 2023 annual scientific meeting in Washington DC, USA, a panel of speakers delivered presentations on why patient-centred...
US Patent Office Grants Notice of Allowance to IceCure for its...
IceCure Medical has shared in a press release that it has received a Notice of Allowance from the US Patent and Trademark Office for...
Truveta announces collaboration with Boston Scientific to advance post-procedure patient insights...
Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities. Through this collaboration, Boston...
ECIO 2022 sees launch of landmark foundation IO course: Q&A with...
The 2022 European Congress on Interventional Oncology (ECIO) took place 24–27 April in Vienna, Austria. Interventional News spoke to chairman Philippe Pereira (SLK-Kliniken, Stuttgart,...
ECR 2022: Interventional oncology is the fourth pillar of oncology—a shift...
With cancer cases growing worldwide and an increased number of late-stage diseases in elderly patients, there is an increasing need for an integrated approach....
New consensus guidelines will facilitate interventional oncology research
We are facing several problems in the field of clinical oncology research, by which I mean that study results are being collected, analysed and...
Guidelines will boost interventional oncology research
The development of new research guidelines for interventional oncology that standardise treatment outcomes and the reporting of data represents a major step forward for...
CAVA RCT delivers powerful evidence supporting use of PORTs to supply...
For most patients receiving systemic anticancer treatment (SACT), totally implanted ports (PORTs) are more effective and safer than both Hickman-type tunnelled catheters (Hickman) and...
Radioembolization can be used as a bridge to surgery in HCC...
Using selective internal radiation therapy (SIRT) to down-stage hepatocellular carcinoma (HCC) tumours or act as a bridge to surgery is feasible for both small...
COLDFIRE 2: IRE is safe, effective in patients unsuitable for thermal...
Irreversible electroporation (IRE) is an effective and relatively safe treatment for colorectal liver metastases 5cm or smaller that are deemed unsuitable for partial hepatectomy,...
AB-LATE02 randomised trial to probe “synergistic” immunotherapy and ablation strategy for...
A randomised trial—AB-LATE02—will assess the efficacy of a combination of neoadjuvant atezolizumab, and adjuvant atezolizumab and bevacizumab with radiofrequency ablation (RFA) as a treatment...
IASIOS, the world’s first accreditation programme for interventional oncology, just opened...
The International Accreditation System for Interventional Oncology Services (IASIOS) has passed its pilot phase with flying colours, the Cardiovascular and Interventional Radiological Society of...
Ablation-confirmation software must become the new normal for IRs to be...
“If interventional radiologists wish to become competitive with surgeons, the availability of software enabling the accurate comparison of pre- and post-interventional CT or...
Novel embolic device used for arterial and venous tumour treatments
Fluidx Medical Technology has announced that GPX Embolic Device first patient use cases were presented at LINC 2021 (25–29 January, online).
“This is very promising...
Artificial intelligence should be incorporated into interventional oncology curricula to advance...
“Artificial intelligence is changing the face of healthcare for all stakeholders, from consumers to providers,” Stephen Hunt (University of Pennsylvania, Philadelphia, USA; co-founder...
Ten-year data at single institution support thermal lung ablation as a...
Thermal lung ablation (TLA) is an effective treatment, resulting in good overall survival with good local control, attendees were told at the 2020 annual...
Cancer treatment beyond systemic chemotherapy: Local intra-tumoural injections demonstrate abscopal effect
Preclinical and clinical studies show that local, intra-tumoural injection of immunomodulatory agents can result in the shrinking of tumours distant from the site of...
The evolving role of hepatic ablation
Raul Uppot (Massachusetts General Hospital, Boston, USA) speaks to Interventional News about the evolution of hepatic ablation, following his talk on the same topic at...
Combination of immuno-oncology and liver-directed therapy: Where do we stand?
Ushering in “the era of IO”, Brad Wood calls for interventional oncologists to learn the language of immuno-oncology—“the other IO”—in order to improve care...
Sirtex Medical partners with Magle Chemoswed to develop imaging agent
Sirtex Medical has announced a collaboration with Magle Chemoswed, a Sweden-based contract development and manufacturing organisation.
The development and commercial agreement grants Sirtex global use...
Interventional Oncology 2.0: Soul-searching to define our identity
Julius Chapiro and Lynn Savic claim there is “no need for scepticism” about the recent emergence and growth of immuno-oncology from an interventional oncologists’...
Bill Rilling
Instrumental to the development of interventional oncology in the USA and globally, William (Bill) Rilling tracks how the discipline has grown over the course...
Lipidol Ultra-Fluid recevies approval for use in cTACE by China NMPA
Guerbet has announced the approval of an additional indication for Lipiodol Ultra-Fluid by the China NMPA (National Medical Products Administration) for use in transarterial...
International accreditation scheme “brings IO into the mainstream”
The newly established International Accreditation System for Interventional Oncology Services (IASIOS) gives medical facilities the opportunity to receive credentials for their interventional oncology (IO)...
CIRSE 2019: Teaching materials to follow curriculum in IO education
CIRSE 2019 Gold Medal awardee, Thierry de Baère (Villejuif, France), tells Interventional News at the society’s annual meeting (7-11 September, Barcelona, Spain) that this...
What is an interventional oncologist?
Society of Interventional Oncology (SIO) president William (Bill) Rilling notes that you do not need to be a full time cancer specialist to describe...
First in man study of robotically-assisted sonic therapy concludes the technique...
Preliminary results of a first in man trial demonstrate that robotically-assisted sonic therapy (RAST) can create a planned ablation volume without significant device-related adverse...
Together, IO and RO can increase the scope of local tumour...
Bringing interventional oncology (IO) and radiation oncology (RO) closer together would yield more than important logistical gains for IO; it would open up a...
Interventional oncology established in “mainstream” cancer care with world-first clinical symposium
The world-first collaboration between interventional oncology (IO) and radiation oncology, embraced by the Trans-Tasman Radiation Oncology Group (TROG), continues to bear fruit, with the...
SIR advocates for a reallocation of Capitol funding to increase interventional...
At the third Capitol briefing from the Society of Interventional Radiology (SIR), Susan Sedory, executive director for SIR, along with a panel of experienced...
Involving interventional oncologists in gene therapies could cut the prohibitive costs
Daniel Sze (Stanford University, Stanford, USA), presenting at the European Conference on Interventional Oncology Annual Meeting (ECIO; 22–25 April, Vienna, Austria), calls for a...
WCIO 2018 puts biopsy front and centre of the interventional oncology...
The opening plenary at the World Conference on Interventional Oncology (WCIO; 7–10 June, Boston, USA) put biopsy, which is considered a mundane procedure by...
Stephen B Solomon
Stephen B Solomon, chief, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, USA and president of the Society for Interventional Oncology (SIO)...
Artificial intelligence will support clinical decision making in interventional oncology
Aaron Abajian and Julius Chapiro, New Haven, USA, write about results from an early experiment in applying artificial intelligence (AI) and machine learning as a...
Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE
Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...
Targeted immunotherapy treatment shows promise for treating for advanced liver cancer
Advanced stage liver tumours may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to phase 1 data presented at...
Clinical capabilities of Infinix-i 4D CT showcased at ECR 2018
Healthcare centres around Europe are realising a new realm of clinical efficiency with the Infinix-i 4D CT system, which seamlessly integrates interventional radiology and...
Varian signs agreement to acquire Sirtex
Varian Medical has announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical for A$28 per share in cash....
Northwestern University adopts radioembolization with TheraSphere as first-line treatment for HCC
BTG has announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois, USA, has adopted Y-90...
Future directions for ablation in interventional oncology
The notion of locally destroying a cancer percutaneously with minimal morbidity and mortality has become accepted as part of the modern armamentarium for treating...
Vast majority of patients prefer radial access for embolization therapies in...
“While both radial and femoral accesses are safe and effective for transarterial liver embolization, it is clear that the patients prefer radial access,” said Marcelo Guimaraes, Charleston, USA, who was presenting on the...
Mentice aims to reduce TACE procedure times and radiation exposure with...
Mentice has announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software was showcased at the 2017 CIRSE...
BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme
BTG and the Society of Interventional Oncology (SIO) have expanded their commitment to the Immuno-oncology /interventional oncology research grant programme, by announcing a second...
Stephen Solomon assumes Society of Interventional Oncology presidency
The Society of Interventional Oncology (SIO) has announced new officers and a Board of Directors.
Stephen Solomon, chief of Interventional Radiology at Memorial Sloan Kettering...
Radiofrequency ablation used to treat cancer pain for patients
Interventional radiologists at the Emory Johns Creek Hospitals (EJCH), Johns Creek, USA, are using radiofrequency ablation to reduce pain for cancer patients.
Radiofrequency ablation is...
SIO announces first grants in interventional oncology /immuno-oncology research programme
The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients.
The interventional oncology /immuno-oncology research programme...
